查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2106659

心臟心律不整監測設備：市場洞察、競爭格局與市場預測 - 2034 年

Cardiac Arrhythmia Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

概述：

  • 到2025年，心臟心律不整監測設備市場規模達到 71.2億美元，預計到2034年將達到 132.8億美元。該成長是由全球房顫和其他心律不整負擔的加重、穿戴式和遠端攜帶式監測技術的快速普及以及人工智慧驅動的心律不整檢測演算法的日益廣泛應用所推動的。
  • 全球心臟心律不整監測設備市場預計在2026年至2034年的預測期內將以 7.17%的CAGR成長。
  • 依設備類型分類，到2025年， 心電圖監測細分市場佔35%的佔有率，推動心臟心律不整監測設備市場的發展。
  • 依監測類型分類，到2025年，連續監測細分市場引領心律不整監測設備市場，佔據 64%的市場佔有率。
  • 依應用領域分類，到2025年，心房顫動（AFib）領域引領心臟心律不整監測設備市場，佔 46%。
  • 依最終用戶分類，醫院和診所領域引領心臟心律不整監測設備市場，到2025年佔市場佔有率的42%。
  • 到2025年，北美以 38%的銷售額引領全球心臟心律不整監測設備市場，在全球區域市場佔有率中佔據最高地位。

心律不整監測設備是專門用於檢測、記錄、傳輸和分析心臟異常電活動的醫療技術，有助於診斷和治療心房顫動、心搏過緩過緩和心搏過速等疾病。由於心律不整發作通常是短暫的、無症狀的或不頻繁的，臨床醫生會使用各種攜帶式和植入式技術，從短期心電圖監測和事件記錄儀到長期移動心電遙測（MCT）系統，甚至包括可運行數年的植入式心臟監測儀，以便在臨床環境之外收集可操作的心率資料。此市場依攜帶式類型可分為心電圖監測、心臟事件記錄器設備、行動心電遙測（MCT）設備和植入式心臟監測儀，依監測方法可分為連續監測和間歇/事件監測。依應用領域分類，心房顫動是主要目標，其次是心搏過緩、心搏過速和其他心律不整。此外，依終端用戶分類，市場可細分為醫院和診所、門診手術中心、診斷和心臟中心以及居家醫療/遠端患者監護環境。在全球心血管疾病盛行率不斷上升的背景下，攜帶式設備無線連接的快速小型化和發展，以及人工智慧（AI）與心律不整檢測演算法的融合，使得心臟心律不整監測設備成為支持早期診斷、遠端患者管理和個人化心臟護理的重要基礎設施。

心臟心律不整監測設備市場的主要市場促進因素

  • 全球範圍內心房顫動和其他心律不整的盛行率不斷上升，推動了市場需求，預計到2030年，美國將有 1,220萬人患有心房顫動。
  • 穿戴式、貼片式和無線心電圖監測技術的快速發展推動其應用。例如，iRhythm公司獲得FDA已通過核准的行動心電遙測增強產品Zio AT，以及該公司計劃於2025年進軍日本市場。
  • 將基於人工智慧的演算法整合到植入式心臟監視器中，可以減少誤報並提高診斷準確性。MedtronicLINQ II植入式心臟監視器上的AccuRhythm人工智慧平台就證明了這一點。
  • 持久型植入式心臟監視器領域競爭日益激烈，活性化，其中Abbott的Assert-IQ 設備電池壽命長達六年，這日益擴大需要長期心率監測的患者的潛在市場。
  • 隨著遠端患者監護和居家醫療模式的日益普及，心律不整的診斷正從醫院環境轉移到分散的、對病人友善的監護環境。
  • 已開發市場擴大門診和行動心電遙測服務的保險覆蓋範圍，改善長期監測的可及性。
  • 心血管疾病負擔日益加重、穿戴式技術的創新、人工智慧驅動的分析以及遠端監測的廣泛應用都是推動市場成長的因素，預計到2034年，市場將保持穩定成長。

推動心臟心律不整監測設備市場成長的因素

市場促進因素

全球心房顫動和心律不整盛行率不斷上升

心臟心律不整監測設備市場最強勁的促進因素是全球心房顫動及相關心律不整盛行率的不斷上升。心房顫動是最常見的持續性心律不整，公共衛生部門預測，到2030年，光在美國就有約1,220萬人患有心房顫動。人口老化、肥胖、糖尿病和高血壓盛行率的上升，以及臨床醫師對未確診心房顫動相關中風風險的認知不斷提高，都促使需要心率監測的患者群體不斷擴大。由於心律不整發作通常呈間歇性且無症狀，醫生擴大開立長期攜帶式監測設備，包括心電圖監測、心臟事件記錄器記錄儀、移動心電遙測設備和植入式心臟監測器，以獲取可操作的心率資料。隨著疾病盛行率和診斷意識的不斷提高，對心律不整監測能力的需求將直接擴大，推動市場成長至2034年。

穿戴式和攜帶式心電圖監測技術的快速發展

穿戴式、貼片式和無線心電圖監測技術的持續創新是該市場的主要成長動力。最新的心電圖監測和行動心電遙測貼片採用緊湊的黏合貼片設計，可連續佩戴長達14天，並具備基於雲端的資料傳輸功能，與傳統動態心電圖系統相比，提高了患者依從性和診斷準確性。 iRhythm公司的「Zio AT」系統於2025年獲得FDA批准，其設計和顯示性能得到改進，隨後在日本上市，這清晰地展現了向長期、演算法驅動的攜帶式遙測技術的轉變。隨著穿戴式裝置變得更小巧、更舒適，並能善加與智慧型手機連接，其應用範圍正透過醫療轉診和直接面對消費者的銷售不斷擴大，為設備製造商創造了不斷成長的市場。

市場限制因素

儘管心臟心律不整監測設備市場發展動力強勁，但仍面臨諸多限制因素。植入式和先進攜帶式監測設備的高成本仍然是一大障礙，限制了其在價格敏感且償付比例較低的醫療體系中的普及，尤其是在新興經濟體。能夠分析大量攜帶式的熟練心臟技師和電生理學家短缺，限制了設備的普及速度，並可能導致診斷瓶頸，尤其是在監測週期延長和資料量增加的情況下。監管機構對設備設計變更和製造品質的嚴格審查，例如美國食品藥物管理局（FDA）的警告以及攜帶式監測設備製造商遭遇的產品提交延遲，可能會延緩新產品的上市和適應症的擴展。攜帶式和遠端監測服務的償付政策在不同地區仍存在差異，在保險覆蓋範圍有限的市場，新型植入式和人工智慧驅動設備的普及速度緩慢。患者依從性的挑戰，例如設備移除、黏性貼片引起的皮膚刺激以及通訊連接不穩定等，都可能降低實際臨床應用中的診斷效果。儘管有強勁的潛在促進因素，例如心律不整盛行率上升、穿戴式技術的創新以及遠端監測的廣泛採用，但成本、人才、監管、償付和合規方面的障礙減緩成長速度。

目錄

第1章 心律不整監測設備市場：簡介

  • 調查範圍
  • 市場區隔
  • 市場假設

第2章 心臟心律不整監測設備市場：執行摘要

  • 市場概覽

第3章 心臟心律不整監測設備市場：關鍵因素分析

  • 心臟心律不整監測設備市場：市場促進因素
    • 心房顫動和心律不整盛行率增加
    • 穿戴式和攜帶式心電圖監測技術的進步
    • 將人工智慧應用於心律不整檢測
    • 長壽命植入式心臟監測儀的技術創新
  • 心臟心律不整監測設備市場：限制因素與挑戰
    • 植入式及先進醫療設備高成本
    • 熟練心臟技術人員短缺
    • 法規和償付機制的複雜性
  • 心臟心律不整監測設備市場：市場機會
    • 擴大人工智慧分析和遠端患者監護的範圍
    • 新興市場和居家醫療的擴張

第4章 人工智慧、地緣政治、貿易與經濟趨勢

第5章 監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章 波特五力分析

第7章 心臟心律不整監測設備市場：評估

  • 依設備類型
    • 心電圖監測
    • 心臟事件記錄器設備
    • 移動式心電遙測（MCT）設備
    • 植入式心臟監測器
  • 依監測類型
    • 持續監測
    • 間歇性/事件驅動型監測
  • 依用途
    • 心房顫動（心房顫動）
    • 心搏過緩
    • 心搏過速
    • 其他
  • 依最終用戶
    • 醫院和診所
    • 門診手術中心（ASC）
    • 診斷和心臟中心
    • 居家醫療/遠端患者監護
  • 依地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第8章 心臟心律不整監測設備市場：競爭格局

  • 市場集中度與結構
  • 競爭定位與市場佔有率分析（加值服務）

第9章 心臟心律不整監測設備市場：新創企業資金籌措與投資趨勢

第10章 心臟心律不整監測設備市場：公司概況與產品概況

  • Medtronic PLC
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • GE HealthCare Technologies Inc.
  • iRhythm Technologies, Inc.
  • Biotronik SE & Co. KG
  • Nihon Kohden Corporation
  • Baxter International Inc.
  • LivaNova PLC

第11章 KOL的觀點

第12章 專案方法

第13章 關於 DelveInsight

第14章 免責聲明與聯絡方式

Product Code: DIMDCL0016

Cardiac Arrhythmia Monitoring Devices Market Summary

Overview:

  • The Cardiac Arrhythmia Monitoring Devices market is estimated at USD 7.12 billion in 2025 and is projected to reach USD 13.28 billion by 2034. Growth is anchored in the rising global burden of atrial fibrillation and other rhythm disorders, rapid adoption of wearable and remote ambulatory monitoring technologies, and expanding use of AI-enabled arrhythmia detection algorithms.
  • The global Cardiac Arrhythmia Monitoring Devices market is growing at a CAGR of 7.17% during the forecast period from 2026 to 2034.
  • By device type, the Holter monitors segment dominated the Cardiac Arrhythmia Monitoring Devices market with a 35% share in 2025.
  • By monitoring type, the continuous monitoring segment dominated the Cardiac Arrhythmia Monitoring Devices market with a 64% share in 2025.
  • By application, the atrial fibrillation (AFib) segment dominated the Cardiac Arrhythmia Monitoring Devices market with a 46% share in 2025.
  • By end-user, the hospitals & clinics segment dominated the Cardiac Arrhythmia Monitoring Devices market with a 42% share in 2025.
  • North America dominated the global Cardiac Arrhythmia Monitoring Devices market revenue with a 38% share in 2025, representing the highest regional market share globally.

Cardiac arrhythmia monitoring devices are specialized medical technologies designed to detect, record, transmit, and analyze irregular electrical activity of the heart, supporting the diagnosis and management of conditions such as atrial fibrillation, bradycardia, and tachycardia. Because arrhythmic episodes are frequently transient, asymptomatic, or infrequent, clinicians rely on a spectrum of ambulatory and implantable technologies, ranging from short-term Holter monitors and event recorders to long-wear mobile cardiac telemetry (MCT) systems and multi-year implantable cardiac monitors, to capture actionable rhythm data outside the clinical setting. The market is organized by device type across Holter monitors, event monitoring devices, mobile cardiac telemetry (MCT) devices, and implantable cardiac monitors; by monitoring type across continuous monitoring and intermittent/event-based monitoring; by application, led by atrial fibrillation, alongside bradycardia, tachycardia, and other rhythm disorders; and by end-user across hospitals & clinics, ambulatory surgical centers, diagnostic & cardiac centers, and home healthcare/remote patient monitoring settings. Driven by the rising global prevalence of cardiovascular disease, rapid miniaturization and wireless connectivity of ambulatory devices, and the integration of artificial intelligence into arrhythmia detection algorithms, cardiac arrhythmia monitoring devices have become essential infrastructure underpinning early diagnosis, remote patient management, and personalized cardiac care.

Cardiac Arrhythmia Monitoring Devices Market Key Growth Drivers

  • The rising global prevalence of atrial fibrillation and other rhythm disorders is expanding demand, with an estimated 12.2 million people in the United States projected to have AFib by 2030.
  • Rapid technological advancement in wearable, patch-based, and wireless ECG monitoring is expanding adoption, exemplified by iRhythm's FDA-cleared Zio AT mobile cardiac telemetry enhancements and its 2025 international expansion into Japan.
  • Integration of AI-based algorithms into implantable cardiac monitors is reducing false alerts and improving diagnostic yield, as demonstrated by Medtronic's AccuRhythm AI platform on the LINQ II insertable cardiac monitor.
  • Increasing competitive innovation in long-life implantable cardiac monitors, including Abbott's Assert-IQ device with up to six years of battery life, is expanding the addressable base of long-term rhythm-surveillance patients.
  • Growing adoption of remote patient monitoring and home healthcare models is shifting arrhythmia diagnosis away from inpatient settings toward decentralized, patient-friendly monitoring.
  • Expanding reimbursement coverage for ambulatory and mobile cardiac telemetry services in developed markets is increasing the accessibility of longer-duration monitoring.
  • The convergence of rising cardiovascular disease burden, wearable technology innovation, AI-enabled analytics, and remote monitoring adoption is expected to sustain steady growth in the market through 2034.

Key Companies in Cardiac Arrhythmia Monitoring Devices Market

The competitive landscape is led by the following active device manufacturers:

  • Medtronic
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • GE HealthCare Technologies Inc.
  • iRhythm Technologies, Inc.
  • Biotronik SE & Co. KG
  • Nihon Kohden Corporation
  • Baxter International Inc.
  • LivaNova PLC

Factors Contributing to the Growth of the Cardiac Arrhythmia Monitoring Devices Market

Market Drivers

Rising Global Prevalence of Atrial Fibrillation and Rhythm Disorders

The most powerful driver of the Cardiac Arrhythmia Monitoring Devices market is the rising global prevalence of atrial fibrillation and related rhythm disorders. Atrial fibrillation is the most common sustained cardiac arrhythmia, and public health estimates project that approximately 12.2 million people in the United States alone will have AFib by 2030. Aging populations, rising rates of obesity, diabetes, and hypertension, and greater clinical awareness of the stroke risk associated with undiagnosed AFib are together enlarging the population requiring rhythm surveillance. Because arrhythmic episodes are often intermittent and asymptomatic, physicians increasingly prescribe extended ambulatory monitoring, from Holter and event monitors to mobile cardiac telemetry and implantable cardiac monitors, to capture actionable rhythm data. As disease prevalence and diagnostic awareness continue to climb, demand for arrhythmia monitoring capacity expands directly, anchoring market growth through 2034.

Rapid Technological Advancement in Wearable and Ambulatory ECG Monitoring

Continuous innovation in wearable, patch-based, and wireless ECG monitoring technology is a central growth engine for the market. Modern Holter monitors and mobile cardiac telemetry patches now feature compact, adhesive-patch form factors, extended wear durations of up to fourteen days, and cloud-based data transmission, improving patient compliance and diagnostic yield relative to older Holter systems. iRhythm's Zio AT system, cleared by the FDA for design and labeling enhancements in 2025 and subsequently launched in Japan, illustrates this shift toward long-wear, algorithm-supported ambulatory telemetry. As wearable form factors become smaller, more comfortable, and better integrated with smartphone connectivity, adoption broadens across both hospital-referred and direct-to-consumer monitoring pathways, expanding the addressable market for device manufacturers.

Market Restraints

Despite strong momentum, the Cardiac Arrhythmia Monitoring Devices market faces material constraints. The high cost of implantable and advanced ambulatory monitoring devices remains a significant barrier, limiting adoption in price-sensitive and lower-reimbursement healthcare systems, particularly across emerging economies. A shortage of skilled cardiac technicians and electrophysiologists capable of interpreting large volumes of ambulatory and remote-monitoring ECG data constrains the pace of adoption and can create diagnostic bottlenecks, especially as monitoring durations extend and data volumes rise. Regulatory scrutiny of device design changes and manufacturing quality, illustrated by FDA warning letters and delayed product submissions experienced by ambulatory monitoring providers, can slow new product launches and label expansions. Reimbursement policy for ambulatory and remote monitoring services remains uneven across geographies, and adoption of newer implantable and AI-enabled devices lags in markets with limited payer coverage. Patient compliance challenges, including device removal, skin irritation from adhesive patches, and inconsistent transmission connectivity, can reduce diagnostic yield in real-world use. Together, these cost, workforce, regulatory, reimbursement, and compliance barriers temper the pace of growth, even as the underlying drivers of rising arrhythmia prevalence, wearable innovation, and remote monitoring adoption remain firmly intact.

Cardiac Arrhythmia Monitoring Devices Market Segment Analysis

The Cardiac Arrhythmia Monitoring Devices by Device Type (Holter Monitors, Event Monitoring Devices, Mobile Cardiac Telemetry (MCT) Devices, and Implantable Cardiac Monitors), Monitoring Type (Continuous Monitoring, Intermittent/Event-based Monitoring), Application (Atrial Fibrillation (AFib), Bradycardia, Tachycardia, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers (ASCs), Diagnostic & Cardiac Centers, and Home Healthcare/Remote Patient Monitoring), and Geography (North America, Europe, Asia-Pacific, and Rest of World).

By Device Type

Dominant Subsegment: Holter Monitors.

Dominant: Holter Monitors ~ 35%

The Holter monitors segment accounted for 35% of the Cardiac Arrhythmia Monitoring Devices market in 2025. Holter monitors are the leading device type because they remain the most widely prescribed, cost-effective, and clinically established modality for capturing continuous ECG data over short durations, making them the default first-line tool for arrhythmia work-ups across primary care and cardiology practices. Modern Holter monitors now feature wireless connectivity, compact patch-based designs, and cloud-based data sharing, improving patient comfort and enabling faster physician review relative to legacy tape- and disk-based systems. Their broad reimbursement coverage, established clinical guidelines, and familiarity among general cardiologists and primary care physicians sustain large and dependable procedure volumes. While mobile cardiac telemetry and implantable cardiac monitors are growing faster as physicians increasingly prescribe extended-duration monitoring for higher-risk or diagnostically ambiguous patients, the sheer volume, affordability, and clinical ubiquity of Holter monitoring secure the segment's leadership across the forecast period.

By Monitoring Type

Dominant Subsegment: Continuous Monitoring.

Dominant: Continuous Monitoring ~ 64%

The continuous monitoring segment accounted for 64% of the Cardiac Arrhythmia Monitoring Devices market in 2025. Continuous monitoring is the leading monitoring type because most arrhythmias, particularly atrial fibrillation, are paroxysmal and asymptomatic, requiring uninterrupted rhythm capture over extended periods to achieve an accurate diagnosis. Holter monitors, mobile cardiac telemetry systems, and implantable cardiac monitors all provide continuous or near-continuous ECG recording, and clinical evidence consistently shows that continuous monitoring strategies detect substantially more arrhythmic events than intermittent, patient-triggered recording. The growing use of implantable cardiac monitors for multi-year continuous surveillance following cryptogenic stroke or unexplained syncope, combined with AI-enabled analytics that make continuous data streams clinically manageable, reinforces this segment's scale. While intermittent and event-based monitoring remains valuable for patients with infrequent, clearly symptomatic episodes and offers a lower-cost entry point, the superior diagnostic yield of continuous monitoring secures its leadership across the forecast period.

Cardiac Arrhythmia Monitoring Devices Market Region Analysis

Dominant Region: North America

Dominant: North America ~ 38% (Largest)

North America accounted for 38% of the global Cardiac Arrhythmia Monitoring Devices market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a high and rising prevalence of atrial fibrillation, a mature cardiology and electrophysiology infrastructure, broad reimbursement coverage for ambulatory and implantable monitoring services, and clear FDA regulatory pathways, particularly in the United States. North America hosts the largest concentration of leading device manufacturers, including Medtronic, Abbott, Boston Scientific, and iRhythm, and benefits from early adoption of AI-enabled monitoring platforms and remote patient monitoring infrastructure. Rising awareness of arrhythmia detection among patients and healthcare providers, combined with the growing burden of lifestyle-related cardiovascular risk factors such as obesity, diabetes, and hypertension, continues to drive substantial device demand. Strong reimbursement, regulatory clarity, and proximity to leading manufacturers anchor the region's continued leadership across the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Cardiac Arrhythmia Monitoring Devices market. The region's elevated CAGR is driven by rising cardiovascular disease incidence, rapid expansion of cardiology and diagnostic infrastructure, and growing healthcare investment across China, Japan, India, South Korea, and Australia. China is expanding hospital-based cardiology capacity and domestic device manufacturing, Japan is an early adopter of extended-wear ambulatory telemetry exemplified by iRhythm's 2025 Zio launch in the country, and India is emerging as a fast-growing market for cost-effective Holter and event monitoring devices. Government healthcare investment, expanding urban middle-class populations with rising cardiovascular risk factors, and growing awareness of arrhythmia-related stroke risk are accelerating adoption, while regional manufacturers and distributors scale device availability to align with international quality standards. The combination of high disease burden, infrastructure build-out, and rising healthcare spending positions Asia-Pacific as the principal source of incremental growth over the forecast period.

Regional Commentary

North America

North America accounted for 38% of the global Cardiac Arrhythmia Monitoring Devices market revenue in 2025. The United States dominates on the strength of its cardiology infrastructure, favorable reimbursement environment, FDA regulatory clarity, and concentration of leading device manufacturers, while continued innovation in AI-enabled implantable and ambulatory monitoring devices reinforces the region's leadership.

Europe

Europe is a large and advanced regional market, supported by established EMA and national regulatory frameworks, strong cardiology and electrophysiology networks, and growing adoption of AI-enabled implantable cardiac monitors following CE Mark approvals such as Abbott's Assert-IQ device. Adoption across Germany, France, the United Kingdom, Italy, and Spain is supported by expanding reimbursement for extended ambulatory monitoring.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by rising cardiovascular disease incidence, rapid cardiology infrastructure build-out, and growing healthcare investment across China, Japan, India, South Korea, and Australia. China's hospital-capacity expansion, Japan's early telemetry adoption, and India's cost-effective monitoring device uptake are accelerating regional growth.

Rest of World

The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding cardiology and diagnostic infrastructure, rising demand for arrhythmia detection amid growing cardiovascular disease burden, and gradual improvement in reimbursement frameworks are broadening access, while international distribution partnerships support the build-out of regional device availability.

Cardiac Arrhythmia Monitoring Devices Market Competitive Landscape

The Cardiac Arrhythmia Monitoring Devices market is classified as Moderately Concentrated. A group of large, diversified medical device manufacturers with broad cardiac rhythm management portfolios, including Medtronic, Abbott, Boston Scientific, and Biotronik, anchor the top tier through implantable cardiac monitor leadership and multi-decade cardiology relationships, while specialized ambulatory monitoring providers such as iRhythm Technologies compete through wearable patch innovation and AI-enabled analytics, and diversified diagnostic imaging leaders including Philips, GE HealthCare, and Nihon Kohden compete through integrated ECG and hospital monitoring platforms, increasing competition across both the implantable and ambulatory segments.

The competitive landscape can be evaluated across the following dimensions:

  • Market concentration: Moderately concentrated, with diversified cardiac rhythm management leaders competing alongside specialized ambulatory monitoring providers.
  • Leading players: Medtronic, Abbott, and Boston Scientific anchor the top tier through implantable cardiac monitor portfolios and multi-decade cardiology relationships.
  • Geographic reach: Leaders operate global distribution and clinical-support networks; iRhythm's 2025 Zio launch in Japan illustrates continued international expansion by ambulatory monitoring specialists.
  • Product portfolio strength: Top players offer end-to-end portfolios spanning Holter monitors, event recorders, mobile cardiac telemetry, and implantable cardiac monitors.
  • AI and analytics capability: AI-enabled detection algorithms, including Medtronic's AccuRhythm AI and Abbott's AI-supported Assert-IQ analytics, are a decisive competitive advantage.
  • Battery life and device longevity: Competitive differentiation in implantable cardiac monitors centers on battery life, with Abbott's Assert-IQ offering up to six years versus four-to-four-and-a-half-year lifespans for competing devices.
  • Regulatory track record: Sustained FDA and CE Mark clearances for design enhancements and new indications, alongside proven quality-system compliance, are essential to maintaining commercial availability.
  • Manufacturing and connectivity capabilities: Wireless Bluetooth connectivity, cloud-based data platforms, and mobile app integration are key competitive moats across both implantable and ambulatory device categories.
  • Innovation focus: AI-enabled arrhythmia detection, extended-wear wearable patches, longer-life implantable batteries, and remote patient monitoring integration.

Cardiac Arrhythmia Monitoring Devices Market Recent Developmental Activities

In July 2025, InfoBionic received FDA 510(k) clearance for its MoMe ARC(R) device. This advanced remote ECG monitoring device produces Bluetooth diagnostic 6-lead sensors for patient-required cardiac monitoring. It is designed for both inpatient and outpatient use, providing continuous cardiac telemetry monitoring to assist in the detection and analysis of cardiac arrhythmias.

Cardiac Arrhythmia Monitoring Devices Market Segmentation

Cardiac Arrhythmia Monitoring Devices Market by Device Type

  • Holter Monitors
  • Event Monitoring Devices
  • Mobile Cardiac Telemetry (MCT) Devices
  • Implantable Cardiac Monitors

Cardiac Arrhythmia Monitoring Devices Market by Monitoring Type

  • Continuous Monitoring
  • Intermittent/Event-based Monitoring

Cardiac Arrhythmia Monitoring Devices Market by Application

  • Atrial Fibrillation (AFib)
  • Bradycardia
  • Tachycardia
  • Others

Cardiac Arrhythmia Monitoring Devices Market by End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Diagnostic & Cardiac Centers
  • Home Healthcare/Remote Patient Monitoring

Cardiac Arrhythmia Monitoring Devices Market by Geography

  • North America Cardiac Arrhythmia Monitoring Devices Market
  • United States Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • Canada Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • Mexico Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • Europe Cardiac Arrhythmia Monitoring Devices Market
  • Germany Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • United Kingdom Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • France Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • Italy Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • Spain Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • Rest of Europe Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market
  • China Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • Japan Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • India Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • Australia Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • South Korea Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • Rest of Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • Rest of the World (RoW) Cardiac Arrhythmia Monitoring Devices Market
  • Middle East Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • Africa Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
  • South America Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)

Key Takeaways from the Cardiac Arrhythmia Monitoring Devices Market Report Study

  • Market size analysis for the current cardiac arrhythmia monitoring devices market size (2025), and market forecast for 9 years (2026 to 2034).
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
  • Key companies dominating the global cardiac arrhythmia monitoring devices market.
  • Various opportunities available for competitors in the cardiac arrhythmia monitoring devices market space.
  • What are the top-performing segments in 2025? How will these segments perform in 2034?
  • Which are the top-performing regions and countries in the current cardiac arrhythmia monitoring devices market scenario?
  • Which are the regions and countries where companies should concentrate their opportunities for cardiac arrhythmia monitoring devices market growth in the future?

Target audience who can benefit from this cardiac arrhythmia monitoring devices market report study

  • Cardiac arrhythmia monitoring devices product providers
  • Research organizations and consulting companies
  • Cardiac arrhythmia monitoring devices-related organizations, associations, forums, and other alliances.
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in cardiac arrhythmia monitoring devices
  • Various end-users who want to know more about the cardiac arrhythmia monitoring devices market and the latest technological developments in the cardiac arrhythmia monitoring devices market.

Frequently Asked Questions:

Q1. What is the growth rate of the cardiac arrhythmia monitoring devices market?

The cardiac arrhythmia monitoring devices market is projected to expand at a CAGR of 7.17% during the forecast period from 2026-2034.

Q2. What is the market size of the cardiac arrhythmia monitoring devices market?

The cardiac arrhythmia monitoring devices market is estimated at USD 7.12 billion in 2025 and is projected to reach USD 13.28 billion by 2034.

Q3. Which region dominates the Cardiac Arrhythmia Monitoring Devices market?

North America dominated the Cardiac Arrhythmia Monitoring Devices market with a 38% share of global revenue in 2025, supported by a mature cardiology and electrophysiology ecosystem, broad reimbursement coverage, FDA regulatory clarity, and the largest concentration of leading device manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the cardiac arrhythmia monitoring devices market?

The principal drivers are the rising global prevalence of atrial fibrillation and other rhythm disorders, with an estimated 12.2 million people in the United States projected to have AFib by 2030; rapid technological advancement in wearable and ambulatory ECG monitoring; growing integration of AI-based algorithms into arrhythmia detection platforms; competitive innovation in long-life implantable cardiac monitors; and expanding adoption of remote patient monitoring and home healthcare.

Q5. Who are the major players in the cardiac arrhythmia monitoring devices market?

The major players include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., GE HealthCare Technologies Inc., iRhythm Technologies, Inc., Biotronik SE & Co. KG, Nihon Kohden Corporation, Baxter International Inc., and LivaNova PLC, among other active providers profiled in the Competitive Landscape section. Medtronic, Abbott, and Boston Scientific lead through implantable cardiac monitor portfolios and multi-decade cardiology relationships.

Table of Contents

1. Cardiac Arrhythmia Monitoring Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumptions

2. Cardiac Arrhythmia Monitoring Devices Market Executive Summary

  • 2.1 Market at a Glance

3. Cardiac Arrhythmia Monitoring Devices Market Key Factors Analysis

  • 3.1 Cardiac Arrhythmia Monitoring Devices Market Drivers
    • 3.1.1 Rising Prevalence of Atrial Fibrillation and Rhythm Disorders
    • 3.1.2 Technological Advancement in Wearable and Ambulatory ECG Monitoring
    • 3.1.3 Integration of AI into Arrhythmia Detection
    • 3.1.4 Innovation in Long-Life Implantable Cardiac Monitors
  • 3.2 Cardiac Arrhythmia Monitoring Devices Market Restraints and Challenges
    • 3.2.1 High Cost of Implantable and Advanced Devices
    • 3.2.2 Shortage of Skilled Cardiac Technicians
    • 3.2.3 Regulatory and Reimbursement Complexity
  • 3.3 Cardiac Arrhythmia Monitoring Devices Market Opportunities
    • 3.3.1 AI-Enabled Analytics and Remote Patient Monitoring Scale-Up
    • 3.3.2 Emerging-Market and Home Healthcare Expansion

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

  • 5.1 United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Cardiac Arrhythmia Monitoring Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Buyers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Cardiac Arrhythmia Monitoring Devices Market Assessment

  • 7.1 By Device Type
    • 7.1.1 Holter Monitors
    • 7.1.2 Event Monitoring Devices
    • 7.1.3 Mobile Cardiac Telemetry (MCT) Devices
    • 7.1.4 Implantable Cardiac Monitors
  • 7.2 By Monitoring Type
    • 7.2.1 Continuous Monitoring
    • 7.2.2 Intermittent/Event-based Monitoring
  • 7.3 By Application
    • 7.3.1 Atrial Fibrillation (AFib)
    • 7.3.2 Bradycardia
    • 7.3.3 Tachycardia
    • 7.3.4 Others
  • 7.4 By End-User
    • 7.4.1 Hospitals & Clinics
    • 7.4.2 Ambulatory Surgical Centers (ASCs)
    • 7.4.3 Diagnostic & Cardiac Centers
    • 7.4.4 Home Healthcare/Remote Patient Monitoring
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
      • 7.5.1.2 Canada Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
      • 7.5.1.3 Mexico Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
    • 7.5.2 Europe
      • 7.5.2.1 Germany Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
      • 7.5.2.2 United Kingdom Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
      • 7.5.2.3 France Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
      • 7.5.2.4 Italy Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
      • 7.5.2.5 Spain Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
      • 7.5.2.6 Rest of Europe Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
      • 7.5.3.2 Japan Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
      • 7.5.3.3 India Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
      • 7.5.3.4 Australia Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
      • 7.5.3.5 South Korea Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
      • 7.5.3.6 Rest of Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
    • 7.5.4 Rest of World
      • 7.5.4.1 Middle East Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
      • 7.5.4.2 Africa Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)
      • 7.5.4.3 South America Cardiac Arrhythmia Monitoring Devices Market Size in USD million (2023-2034)

8. Cardiac Arrhythmia Monitoring Devices Market Competitive Landscape

  • 8.1 Market Concentration and Structure
  • 8.2 Competitive Positioning and Market Share Analysis (Premium Offering)

9. Cardiac Arrhythmia Monitoring Devices Market Startup Funding and Investment Trends

10. Cardiac Arrhythmia Monitoring Devices Market Company and Product Profiles

  • 10.1 Medtronic PLC
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Service Portfolio
    • 10.1.5 Strategic Initiatives / Entropy
  • 10.2 Abbott Laboratories
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Portfolio
    • 10.2.5 Strategic Initiatives / Entropy
  • 10.3 Boston Scientific Corporation
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Portfolio
    • 10.3.5 Strategic Initiatives / Entropy
  • 10.4 Koninklijke Philips N.V.
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Portfolio
    • 10.4.5 Strategic Initiatives / Entropy
  • 10.5 GE HealthCare Technologies Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Portfolio
    • 10.5.5 Strategic Initiatives / Entropy
  • 10.6 iRhythm Technologies, Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Portfolio
    • 10.6.5 Strategic Initiatives / Entropy
  • 10.7 Biotronik SE & Co. KG
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Portfolio
    • 10.7.5 Strategic Initiatives / Entropy
  • 10.8 Nihon Kohden Corporation
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Portfolio
    • 10.8.5 Strategic Initiatives / Entropy
  • 10.9 Baxter International Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Portfolio
    • 10.9.5 Strategic Initiatives / Entropy
  • 10.10 LivaNova PLC
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Portfolio
    • 10.10.5 Strategic Initiatives / Entropy

For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer and Contact Us

List of Tables

  • Table 1: Cardiac Arrhythmia Monitoring Devices Market in Global (2023-2034)
  • Table 2: Cardiac Arrhythmia Monitoring Devices Market in Global by Device Type (2023-2034)
  • Table 3: Cardiac Arrhythmia Monitoring Devices Market in Global by Monitoring Type (2023-2034)
  • Table 4: Cardiac Arrhythmia Monitoring Devices Market in Global by Application (2023-2034)
  • Table 5: Cardiac Arrhythmia Monitoring Devices Market in Global by End-Users (2023-2034)
  • Table 6: Cardiac Arrhythmia Monitoring Devices Market in Global by Geography (2023-2034)
  • Table 7: Cardiac Arrhythmia Monitoring Devices Market in North America (2023-2034)
  • Table 8: Cardiac Arrhythmia Monitoring Devices Market in the United States (2023-2034)
  • Table 9: Cardiac Arrhythmia Monitoring Devices Market in Canada (2023-2034)
  • Table 10: Cardiac Arrhythmia Monitoring Devices Market in Mexico (2023-2034)
  • Table 11: Cardiac Arrhythmia Monitoring Devices Market in Europe (2023-2034)
  • Table 12: Cardiac Arrhythmia Monitoring Devices Market in Germany (2023-2034)
  • Table 13: Cardiac Arrhythmia Monitoring Devices Market in United Kingdom (2023-2034)
  • Table 14: Cardiac Arrhythmia Monitoring Devices Market in France (2023-2034)
  • Table 15: Cardiac Arrhythmia Monitoring Devices Market in Italy (2023-2034)
  • Table 16: Cardiac Arrhythmia Monitoring Devices Market in Spain (2023-2034)
  • Table 17: Cardiac Arrhythmia Monitoring Devices Market in the Rest of Europe (2023-2034)
  • Table 18: Cardiac Arrhythmia Monitoring Devices Market in Asia-Pacific (2023-2034)
  • Table 19: Cardiac Arrhythmia Monitoring Devices Market in China (2023-2034)
  • Table 20: Cardiac Arrhythmia Monitoring Devices Market in Japan (2023-2034)
  • Table 21: Cardiac Arrhythmia Monitoring Devices Market in India (2023-2034)
  • Table 22: Cardiac Arrhythmia Monitoring Devices Market in Australia (2023-2034)
  • Table 23: Cardiac Arrhythmia Monitoring Devices Market in South Korea (2023-2034)
  • Table 24: Cardiac Arrhythmia Monitoring Devices Market in Rest of Asia-Pacific (2023-2034)
  • Table 25: Cardiac Arrhythmia Monitoring Devices Market in the Rest of the World (2023-2034)
  • Table 26: Cardiac Arrhythmia Monitoring Devices Market in the Middle East (2023-2034)
  • Table 27: Cardiac Arrhythmia Monitoring Devices Market in Africa (2023-2034)
  • Table 28: Cardiac Arrhythmia Monitoring Devices Market in South America (2023-2034)
  • Table 29: Competitive Landscape
  • Table 30: Startup Funding and Investment Trends

List of Figures

  • Figure 1: Cardiac Arrhythmia Monitoring Devices Market Drivers
  • Figure 2: Cardiac Arrhythmia Monitoring Devices Market Restraints
  • Figure 3: Cardiac Arrhythmia Monitoring Devices Market Opportunities
  • Figure 4: Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
  • Figure 5: Regulatory Analysis (US, EU, Japan, China)
  • Figure 6: Porter's Five Forces Analysis
  • Figure 7: Competitive Analysis
  • Figure 8: Cardiac Arrhythmia Monitoring Devices Market in Global (2023-2034)
  • Figure 9: Cardiac Arrhythmia Monitoring Devices Market in Global by Device Type (2023-2034)
  • Figure 10: Cardiac Arrhythmia Monitoring Devices Market in Global by Monitoring Type (2023-2034)
  • Figure 11: Cardiac Arrhythmia Monitoring Devices Market in Global by Application (2023-2034)
  • Figure 12: Cardiac Arrhythmia Monitoring Devices Market in Global by End-Users (2023-2034)
  • Figure 13: Cardiac Arrhythmia Monitoring Devices Market in Global by Geography (2023-2034)
  • Figure 14: Cardiac Arrhythmia Monitoring Devices Market in North America (2023-2034)
  • Figure 15: Cardiac Arrhythmia Monitoring Devices Market in the United States (2023-2034)
  • Figure 16: Cardiac Arrhythmia Monitoring Devices Market in Canada (2023-2034)
  • Figure 17: Cardiac Arrhythmia Monitoring Devices Market in Mexico (2023-2034)
  • Figure 18: Cardiac Arrhythmia Monitoring Devices Market in Europe (2023-2034)
  • Figure 19: Cardiac Arrhythmia Monitoring Devices Market in Germany (2023-2034)
  • Figure 20: Cardiac Arrhythmia Monitoring Devices Market in United Kingdom (2023-2034)
  • Figure 21: Cardiac Arrhythmia Monitoring Devices Market in France (2023-2034)
  • Figure 22: Cardiac Arrhythmia Monitoring Devices Market in Italy (2023-2034)
  • Figure 23: Cardiac Arrhythmia Monitoring Devices Market in Spain (2023-2034)
  • Figure 24: Cardiac Arrhythmia Monitoring Devices Market in the Rest of Europe (2023-2034)
  • Figure 25: Cardiac Arrhythmia Monitoring Devices Market in Asia-Pacific (2023-2034)
  • Figure 26: Cardiac Arrhythmia Monitoring Devices Market in China (2023-2034)
  • Figure 27: Cardiac Arrhythmia Monitoring Devices Market in Japan (2023-2034)
  • Figure 28: Cardiac Arrhythmia Monitoring Devices Market in India (2023-2034)
  • Figure 29: Cardiac Arrhythmia Monitoring Devices Market in Australia (2023-2034)
  • Figure 30: Cardiac Arrhythmia Monitoring Devices Market in South Korea (2023-2034)
  • Figure 31: Cardiac Arrhythmia Monitoring Devices Market in Rest of Asia-Pacific (2023-2034)
  • Figure 32: Cardiac Arrhythmia Monitoring Devices Market in the Rest of the World (2023-2034)
  • Figure 33: Cardiac Arrhythmia Monitoring Devices Market in the Middle East (2023-2034)
  • Figure 34: Cardiac Arrhythmia Monitoring Devices Market in Africa (2023-2034)
  • Figure 35: Cardiac Arrhythmia Monitoring Devices Market in South America (2023-2034)
  • Figure 36: Competitive Landscape
  • Figure 37: Startup Funding and Investment Trends